Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 3
2005 1
2006 1
2007 1
2008 1
2018 1
2020 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Acquired resistance to IDH inhibition through trans or cis dimer-interface mutations.
Intlekofer AM, Shih AH, Wang B, Nazir A, Rustenburg AS, Albanese SK, Patel M, Famulare C, Correa FM, Takemoto N, Durani V, Liu H, Taylor J, Farnoud N, Papaemmanuil E, Cross JR, Tallman MS, Arcila ME, Roshal M, Petsko GA, Wu B, Choe S, Konteatis ZD, Biller SA, Chodera JD, Thompson CB, Levine RL, Stein EM. Intlekofer AM, et al. Among authors: takemoto n. Nature. 2018 Jul;559(7712):125-129. doi: 10.1038/s41586-018-0251-7. Epub 2018 Jun 27. Nature. 2018. PMID: 29950729 Free PMC article.
FXR mediates T cell-intrinsic responses to reduced feeding during infection.
Campbell C, Marchildon F, Michaels AJ, Takemoto N, van der Veeken J, Schizas M, Pritykin Y, Leslie CS, Intlekofer AM, Cohen P, Rudensky AY. Campbell C, et al. Among authors: takemoto n. Proc Natl Acad Sci U S A. 2020 Dec 29;117(52):33446-33454. doi: 10.1073/pnas.2020619117. Epub 2020 Dec 14. Proc Natl Acad Sci U S A. 2020. PMID: 33318189 Free PMC article.
Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin.
Intlekofer AM, Takemoto N, Wherry EJ, Longworth SA, Northrup JT, Palanivel VR, Mullen AC, Gasink CR, Kaech SM, Miller JD, Gapin L, Ryan K, Russ AP, Lindsten T, Orange JS, Goldrath AW, Ahmed R, Reiner SL. Intlekofer AM, et al. Among authors: takemoto n. Nat Immunol. 2005 Dec;6(12):1236-44. doi: 10.1038/ni1268. Epub 2005 Nov 6. Nat Immunol. 2005. PMID: 16273099
Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia.
Matsunaga T, Takemoto N, Sato T, Takimoto R, Tanaka I, Fujimi A, Akiyama T, Kuroda H, Kawano Y, Kobune M, Kato J, Hirayama Y, Sakamaki S, Kohda K, Miyake K, Niitsu Y. Matsunaga T, et al. Among authors: takemoto n. Nat Med. 2003 Sep;9(9):1158-65. doi: 10.1038/nm909. Epub 2003 Aug 3. Nat Med. 2003. PMID: 12897778 Free article.
C(H)OP refractory chronic lymphocytic leukemia patients in whom salvage chemotherapy chosen by evaluating multiple chemotherapeutic drug-resistant factors was remarkably effective.
Matsunaga T, Kogawa K, Fujimi A, Takizawa K, Takahira N, Takemoto N, Tanaka I, Akiyama T, Sato T, Takayama T, Terui T, Sakamaki S, Niitsu Y. Matsunaga T, et al. Among authors: takemoto n. Int J Clin Oncol. 2003 Oct;8(5):326-31. doi: 10.1007/s10147-003-0327-7. Int J Clin Oncol. 2003. PMID: 14586760
12 results